Kenneth G Lucas, MD
University of Louisville · University of Louisville, Kosairs Charities Pediatric Clinical Research Unit · Milton S. Hershey Medical Center
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Kenneth G Lucas, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:00 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT02332889 · Phase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CNS PNETsUniversity of Louisville · terminated · Gliomas, Medulloblastoma, Neuroectodermal Tumors, Primitive · principal investigator
- Ph1NCT01483274 · Decitabine and Vaccine Therapy for Patients With Relapsed AML Following Allogeneic Stem Cell TransplantationUniversity of Louisville · withdrawn · Acute Myelogenous Leukemia · principal investigator
- Ph1NCT01241162 · Decitabine Followed by a Cancer Antigen Vaccine for Patients With Neuroblastoma and SarcomaUniversity of Louisville · completed · Neuroblastoma, Ewings Sarcoma, Osteogenic Sarcoma · principal investigator
- Ph1NCT00944580 · A Vaccine Study for High Risk CancersPenn State University · withdrawn · Neuroblastoma, Rhabdomyosarcoma, Osteogenic Sarcoma · study chair
- Ph1NCT00769613 · Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus InfectionsMilton S. Hershey Medical Center · unknown · Cancer · principal investigator
- Ph1NCT00673868 · Cytomegalovirus (CMV) Specific Cytotoxic T Lymphocytes (CTL) When Used for Prophylaxis Against CMV in Recipients of Allogeneic, T Cell Depleted Stem Cell TransplantsMilton S. Hershey Medical Center · completed · Cytomegalovirus Infections · principal investigator
- Ph1NCT00509691 · Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to TherapyUniversity of Louisville · completed · Cancer · principal investigator
- Ph1NCT00436761 · Busulfan, Melphalan, and Antithymocyte Globulin Followed By Umbilical Cord Blood Transplant in Treating Young Patients With Refractory or Relapsed Malignant Solid TumorsMilton S. Hershey Medical Center · unknown · Unspecified Childhood Solid Tumor, Protocol Specific · study chair
- Ph1NCT00112645 · Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid TumorsMilton S. Hershey Medical Center · completed · Neuroblastoma, Sarcoma, Unspecified Childhood Solid Tumor, Protocol Specific · principal investigator
- Ph1NCT00101309 · Vaccine Therapy and Interleukin-2 in Treating Young Patients With Relapsed or Refractory Ewing's Sarcoma or NeuroblastomaMilton S. Hershey Medical Center · unknown · Neuroblastoma, Sarcoma · study chair
- Ph1NCT00002956 · Immunotherapy for Lymphoproliferative Diseases Associated With Epstein-Barr Virus in Patients Who Have Undergone Organ TransplantsUniversity of Alabama at Birmingham · withdrawn · Leukemia, Lymphoma · study chair
- Ph2NCT00084695 · Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant DiseasesMilton S. Hershey Medical Center · unknown · Childhood Langerhans Cell Histiocytosis, Fanconi Anemia, Leukemia · study chair
- Ph1NCT00006100 · Allogeneic Epstein Barr Virus-Specific Cytotoxic T-Lymphocytes in Treating Patients With Progressive, Relapsed, or Refractory Hodgkin's LymphomaMilton S. Hershey Medical Center · unknown · Lymphoma · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:00 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.